đź“‹ FDA Reference
philips heartstart smartpads iii
Philips Medical Systems
Summary: The Philips HeartStart SMART Pads III are defibrillation pads used with Philips HeartStart defibrillators. They are designed for emergency use by healthcare professionals to treat sudden cardiac arrest.
FDA Clearance Information
Pathway
510K
Number
K072812 ↗
Decision Date
February 26, 2008
Product Code
MKJ
Device Class
Class 3
Evidence
419 studies
The Philips HeartStart SMART Pads III were cleared through the FDA 510k pathway on February 26, 2008. Manufactured by Philips Medical Systems, this Class 3 device is coded under MKJ.
What It Is
The Philips HeartStart SMART Pads III are adhesive electrode pads used in conjunction with Philips HeartStart defibrillators. They deliver electrical shocks to the heart in cases of sudden cardiac arrest. These pads are designed to be quickly and easily applied to a patient's bare chest, providing a critical link in the chain of survival during cardiac emergencies.
Clinical Applications
These defibrillation pads are commonly used in emergency settings such as hospitals, ambulances, and public access defibrillation programs. They are essential in cardiology and emergency medicine, particularly for patients experiencing ventricular fibrillation or pulseless ventricular tachycardia. The pads are suitable for both adult and pediatric patients, making them versatile in various clinical scenarios.
Indications for Use
The FDA-cleared indications for the Philips HeartStart SMART Pads III include use in patients experiencing sudden cardiac arrest. They are intended for rapid defibrillation to restore normal heart rhythm in life-threatening situations.
Practical Considerations
The SMART Pads III are compatible with Philips HeartStart defibrillators and are designed for single-use. They come in adult and pediatric sizes, with clear instructions for placement to ensure effective delivery of therapy. Clinicians should ensure the pads are within their expiration date and stored properly to maintain functionality.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Philips HeartStart SMART Pads III used for?
They are used for delivering defibrillation shocks to patients in cardiac arrest.
What specialties typically use this device?
Cardiology, emergency medicine, and pre-hospital emergency services.
What are the FDA-cleared indications?
For use in patients experiencing sudden cardiac arrest to restore normal heart rhythm.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.